Navigation Links
Viral Genetics' Researcher and Advisor Set to Share Award
Date:2/15/2011

://www.timeforlyme.org/">www.timeforlyme.org.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports. None of Viral Genetics' drug compounds are approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. While Viral Genetics believes that the forward-looking statements and underlying assumptions reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Viral Genetics to establish the efficacy of any of its drug therapies in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of those drug compounds in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by Viral Genetics or any other person that the objectives and plans of Viral Genetics will be achieved.

www.viralgenetics.com Contact: Haig Keledjian, Viral GeneticsT: (626) 334-5310info@viralgenetics.com
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Viral Genetics Issues 2010 Year in Review, 2011 Outlook
2. Zacks Investment Research Initiates Coverage on Viral Genetics
3. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
4. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
5. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
6. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
7. AASLD Presidents Choice Lecture: The National Strategy for the Control of Viral Hepatitis and Liver Cancer
8. Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes
9. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
10. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
11. New American Therapeutics Acquires Antiviral Drug Denavir®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... WALTHAM, Mass. , May 26, 2015 /PRNewswire/ ... the 62 nd Annual Meeting of the ... methods of monitoring patient respiration in hospitals miss ... serious risks to patients. The findings conclude that ... by Respiratory Motion, Inc. more consistently protects patients ...
(Date:5/26/2015)... , May 26, 2015 Boehringer Ingelheim ... Administration (FDA) approved once-daily STIOLTO™ RESPIMAT ® ... been approved as a long-term, once-daily maintenance treatment ... pulmonary disease (COPD), including chronic bronchitis and/or emphysema. ... or acute deterioration of COPD. COPD, ...
(Date:5/26/2015)... , May 26, 2015  Organovo Holdings, Inc. ... on delivering breakthrough 3D bioprinting technology, announced today that ... the Jeffries 2015 Healthcare Conference, to be held in ... 4, 2015.  Keith Murphy , Chairman and Chief ... recent key advances and partnerships. Details of ...
Breaking Medicine Technology:Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 2Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 3
... may still seem radically innovative in the context of ... had been the norm for many years. In automobile ... vehicles with only occasional human oversight. The result has ... positive returns in profit and productivity. These days, only ...
... necessary to plan or evaluate anticoagulant therapy, ... hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor ... and to assess acquired conditions, such as ... others. Prothrombin levels are also monitored along ...
Cached Medicine Technology:Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4Prothrombin Time Comes in Small (CLIA-Waived) Packages 2Prothrombin Time Comes in Small (CLIA-Waived) Packages 3
(Date:5/26/2015)... Viejo, CA (PRWEB) May 26, 2015 ... styles for Final Cut Pro X . ... suspenseful to simple and elegantly styled text. , ... in seconds. , ProTrailer Network can easily complement any ... style desired and within seconds can make professional looking ...
(Date:5/26/2015)... Ore. (PRWEB) May 26, 2015 ... association which provides talent development to credit union CEOs, ... for their employees to boost the bottom line. CUES ... program that has helped dozens of credit unions across ... According to a 2014-2015 Staff Benefits Report ...
(Date:5/26/2015)... May 26, 2015 Foot and ... Dr. Enzo J. Leone (Pasadena and Baltimore Divisions) ... the Maryland Podiatric Medical Association (MPMA) President from 2013 ... Leone received his Doctorate in Podiatric Medicine from Temple ... West Jersey Hospital in Voorhees, New Jersey. Dr. ...
(Date:5/26/2015)... Boston, MA. (PRWEB) May 26, 2015 ... Standing option in their online Master of Social ... Program sites and on the Charles River Campus, the ... , This Advanced Standing option is open ... by the Council on Social Work Education. Students entering ...
(Date:5/25/2015)... According to the National Library of Medicine, one ... degenerative eye disease. The National Library of Medicine also states ... dyskinesia , a rare disorder that causes sporadic muscle behavior ... these two diseases are more than a statistic – they’re ... shoes with his new autobiography “ The Way I ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:CUES Expects a Positive Return on Wellness with hubbub health™ 2Health News:CUES Expects a Positive Return on Wellness with hubbub health™ 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3Health News:Joseph K. Chan Finds Faith from Disability in New Autobiography 2
... Studies show combo chemotherapy, new drug prolonged lives of ... News) -- Researchers report they prolonged survival for some ... the median survival is currently only about six months. ... called crizotinib shrank tumors in the majority of lung ...
... - Dasatanib, a medication currently approved as treatment for ... better responses as a first therapy than the existing ... Texas MD Anderson Cancer Center. The findings were ... Society of Clinical Oncology today, and published in the ...
... In a ... ahm are paying tribute to local people helping and inspiring others. , ... (PRWEB) June 5, 2010 -- i98FM and ahm ... ahm Local Hero Awards., , , , ,In a joint effort to recognise Illawarra residents ...
... ... 600 persons in drug rehabs and prisons , ... (PRWEB) June 5, 2010 -- President Narconon International, Clark ... unique Narconon® drug-free withdrawal and relapse prevention technology to Mexico. Accompanied by U.S. and ...
... ... promising to make online buying a simple, easy one-stop shopping experience. , ... (PRWEB) June 5, 2010 -- With online shopping ... many choices, shipping arrangements and payment procedures that it is easy to get confused, which ...
... to new research that will be presented on Saturday, June ... of Dental Sleep Medicine, nasendoscopy may help dentists predict oral ... flexible endoscope being inserted through the nasal cavity. The tip ... velopharynx and oro-/hypopharynx. OAT has been shown to be ...
Cached Medicine News:Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Second-line CML drug evokes faster response, fewer side effects, pivotal study finds 2Health News:i98 Fm And ahm Announce Local Hero Finalists 2Health News:i98 Fm And ahm Announce Local Hero Finalists 3Health News:Narconon Campaigns to Help Mexico Reduce Drug-related Violence in Sonora and Michoacan 2Health News:BestMassage.com Launches Its Brand New Customer-Focused Website 2Health News:Nasendoscopy proves useful in predicting treatment success in sleep apnea patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: